Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 39, 2005 - Issue sup216
Submit an article Journal homepage
73
Views
40
CrossRef citations to date
0
Altmetric
Original Article

Prognostic and predictive factors in prostate cancer: Historical perspectives and recent international consensus initiatives

John R. Srigley Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, CanadaCorrespondence[email protected]
,
Mahul Amin Departments of Pathology and Laboratory Medicine, Urology, Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia, USA
,
Liliane Boccon-Gibod Pathology Department, Faculté de Médecine Saint-Antoine, Hôpital Armand Trousseau, Paris, France
,
Lars Egevad Department of Pathology and Cytology, Karolinska University Hospital Solna, Stockholm, Sweden
,
Jonathan I. Epstein Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland, USA
,
Peter A. Humphrey Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA
,
Gregor Mikuz Department of Pathology, University of Innsbruck School of Medicine, Innsbruck, Austria
,
Don Newling Global Physician Urology, AstraZeneca, Macclesfield, UK
,
Sten Nilsson Department of Oncology, Karolinska University Hospital Solna, Stockholm, Sweden
,
Wael Sakr Department of Pathology, Wayne State University School of Medicine, Harper University Hospital, Detroit, Michigan, USA
,
Thomas M. Wheeler Department of Pathology, Baylor College of Medicine, Houston, Texas, USA
&
Rodolfo Montironi Institute of Pathological Anatomy and Histopathology, School of Medicine, Polytechnic University of the Marche Region (Ancona), Ancona, Italy
 show all
Pages 8-19 | Published online: 09 Jul 2009

Citations (40)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

George J. Netto & Jonathan I. Epstein. (2010) Theranostic and prognostic biomarkers: genomic applications in urological malignancies. Pathology 42:4, pages 384-394.
Read now

Articles from other publishers (39)

Matthew A. Borg, Michael E. O’Callaghan, Kim L. Moretti & Andrew D. Vincent. (2024) External validation of predictive models of sexual, urinary, bowel and hormonal function after surgery in prostate cancer subjects. BMC Urology 24:1.
Crossref
Meredith Elana Giuliani, Eleni Giannopoulos, Mary Krystyna Gospodarowicz, Michaela Broadhurst, Brian O’Sullivan, Zuzanna Tittenbrun, Sonali Johnson & James Brierley. (2021) Examining the Landscape of Prognostic Factors and Clinical Outcomes for Cancer Control. Current Oncology 28:6, pages 5155-5166.
Crossref
Shengjie Yu, Huihong Yu, Yuanfeng Zhang, Chuan Liu, Weili Zhang & Yunyun Zhang. (2021) Long non-coding RNA LINC01116 acts as an oncogene in prostate cancer cells through regulation of miR-744-5p/UBE2L3 axis. Cancer Cell International 21:1.
Crossref
Shengming Yi, Guiyuan Li & Biaofeng Sun. (2020) Overexpression of LINC00852 promotes prostate cancer cell proliferation and metastasis. Asia-Pacific Journal of Clinical Oncology 17:6, pages 435-441.
Crossref
Changlei Yao, Xianghua Cheng, Xiuquan Guo, Xulou Lu, Fan Bu & Yanfen Xu. (2020) NNT-AS1 modulates prostate cancer cell proliferation, apoptosis and migration through miR-496/DDIT4 axis. Cancer Cell International 20:1.
Crossref
Guangyi Shan, Bo Shao, Qiang Liu, Yu Zeng, Cheng Fu, Ang Chen & Qiguang Chen. (2020) circFMN2 Sponges miR-1238 to Promote the Expression of LIM-Homeobox Gene 2 in Prostate Cancer Cells. Molecular Therapy - Nucleic Acids 21, pages 133-146.
Crossref
Guang Yang, Hubin Yin, Fan Lin, Shun Gao, Kai Zhan, Hang Tong, Xueyong Tang, Qi Pan & Xin Gou. (2020) Long noncoding RNA TUG1 regulates prostate cancer cell proliferation, invasion and migration via the Nrf2 signaling axis. Pathology - Research and Practice 216:4, pages 152851.
Crossref
Yanlan Yu, Fengbin Gao, Qian He, Gonghui Li & Guoqing Ding. (2020) lncRNA UCA1 Functions as a ceRNA to Promote Prostate Cancer Progression via Sponging miR143. Molecular Therapy - Nucleic Acids 19, pages 751-758.
Crossref
R.T. Dess & D.E. Spratt. (2020) Why the UK Should Consider Gene Expression Testing in Prostate Cancer. Clinical Oncology 32:3, pages 149-155.
Crossref
Laurent Brureau, Elise Emeville, Carole Helissey, Jean Pierre Thome, Luc Multigner & Pascal Blanchet. (2019) Endocrine disrupting‐chemicals and biochemical recurrence of prostate cancer after prostatectomy: A cohort study in Guadeloupe (French West Indies). International Journal of Cancer 146:3, pages 657-663.
Crossref
David G. Bostwick & Liang Cheng. 2020. Urologic Surgical Pathology. Urologic Surgical Pathology 415 525.e42 .
Xiaobin Wang, Xi Wang, Zhiyi Zhu, Wensheng Li, Guoqiang Yu, Zhaohui Jia & Xiangwei Wang. (2019) Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma. Biomedicine & Pharmacotherapy 117, pages 109109.
Crossref
Xunda LuoJasvir S. KhuranaNirag JhalaHuaqing ZhaoHe Wang. (2019) The Association of Invasive Cribriform Lesions With Adverse Prostatic Adenocarcinoma Outcomes: An Institutional Experience, Systematic Review, and Meta-analysis. Archives of Pathology & Laboratory Medicine 143:8, pages 1012-1021.
Crossref
Bin Yang, Xiaodi Tang, Zhixin Wang, Daju Sun, Xin Wei & Youpeng Ding. (2018) TUG1 promotes prostate cancer progression by acting as a ceRNA of miR-26a. Bioscience Reports 38:5.
Crossref
Bin Yang, Ge Gao, Zhixin Wang, Daju Sun, Xin Wei, Yanan Ma & Youpeng Ding. (2018) Long non-coding RNA HOTTIP promotes prostate cancer cells proliferation and migration by sponging miR-216a-5p . Bioscience Reports 38:5.
Crossref
George J. Netto, Marie-Lisa Eich & Sooryanarayana Varambally. (2017) Prostate Cancer: An Update on Molecular Pathology with Clinical Implications. European Urology Supplements 16:12, pages 253-271.
Crossref
George J. Netto. (2015) Molecular Updates in Prostate Cancer. Surgical Pathology Clinics 8:4, pages 561-580.
Crossref
Nevenka Miličević, Milanka Mrčela, Josip Galić & Ksenija Marjanović. (2015) Expression of proinflammatory cytokine interleukin-6 in tissue samples of human prostate obtained by needle biopsy. Pathology - Research and Practice 211:11, pages 865-870.
Crossref
S. Biesterfeld. (2014) Dokumentationsqualität histopathologischer Befundberichte von ProstatastanzbiopsienDocumentation quality of histopathology reports of prostate needle biopsies. Der Urologe 53:11, pages 1644-1650.
Crossref
Shadia M Ihlaseh‐Catalano, Sandra A Drigo, Carlos M N de Jesus, Maria Aparecida C Domingues, José Carlos S Trindade Filho, João Lauro V de Camargo & Silvia R Rogatto. (2013) STEAP 1 protein overexpression is an independent marker for biochemical recurrence in prostate carcinoma . Histopathology 63:5, pages 678-685.
Crossref
George J. Netto. (2013) Clinical Applications of Recent Molecular Advances in Urologic Malignancies. Advances in Anatomic Pathology 20:3, pages 175-203.
Crossref
Massimo Mascolo, Daniela Russo & Gaetano De Rosa. 2013. Prostate Cancer: Shifting from Morphology to Biology. Prostate Cancer: Shifting from Morphology to Biology 3 42 .
George J. Netto & Liang Cheng. (2012) Emerging Critical Role of Molecular Testing in Diagnostic Genitourinary Pathology. Archives of Pathology & Laboratory Medicine 136:4, pages 372-390.
Crossref
Brett Delahunt, Rose J Miller, John R Srigley, Andrew J Evans & Hemamali Samaratunga. (2011) Gleason grading: past, present and future. Histopathology 60:1, pages 75-86.
Crossref
George J. Netto. (2011) Molecular Diagnostics in Urologic Malignancies: A Work in Progress. Archives of Pathology & Laboratory Medicine 135:5, pages 610-621.
Crossref
George J. Netto & Jonathan I. Epstein. 2011. Diagnostic Immunohistochemistry. Diagnostic Immunohistochemistry 593 661 .
David G. Bostwick & Isabelle Meiers. 2008. Urologic Surgical Pathology. Urologic Surgical Pathology 442 579 .
. 2007. Clinical Pathology of Urological Tumours. Clinical Pathology of Urological Tumours 101 166 .
Tomaso Prayer‐Galetti, Emilio Sacco, Francesco Pagano, Marina Gardiman, Antonio Cisternino, Giovanni Betto & Paolo Sperandio. (2007) Long‐term follow‐up of a neoadjuvant chemohormonal taxane‐based phase II trial before radical prostatectomy in patients with non‐metastatic high‐risk prostate cancer. BJU International 100:2, pages 274-280.
Crossref
Anja Rabien, Mick Burkhardt, Monika Jung, Florian Fritzsche, Martin Ringsdorf, Hanka Schicktanz, Stefan A. Loening, Glen Kristiansen & Klaus Jung. (2007) Decreased RECK Expression Indicating Proteolytic Imbalance in Prostate Cancer is Associated with Higher Tumor Aggressiveness and Risk of Prostate-Specific Antigen Relapse after Radical Prostatectomy. European Urology 51:5, pages 1259-1266.
Crossref
Johan Braeckman & Dirk Michielsen. 2007. Prostate Cancer. Prostate Cancer 25 32 .
Ivan Damjanov & Gregor Mikuz. 2007. Cancer Grading Manual. Cancer Grading Manual 55 63 .
M Schostak, H Krause, K Miller, M Schrader, S Weikert, F Christoph, C Kempkensteffen & J Kollermann. (2006) Quantitative real-time RT-PCR of CD24 mRNA in the detection of prostate cancer. BMC Urology 6:1.
Crossref
Louis Jean Denis & Padraig R. Warde. 2003. TNM Online. TNM Online.
Rodolfo Montironi, Remigio Vela Navarrete, Antonio Lopez-Beltran, Roberta Mazzucchelli, Gregor Mikuz & Aldo V. Bono. (2006) Histopathology reporting of prostate needle biopsies. 2005 update. Virchows Archiv 449:1, pages 1-13.
Crossref
Hani H. Rashid & Kenneth S. Koeneman. (2006) Prostate cancer: Molecular approaches for detection and prognosis, and angiogenic therapeutic targets. Urologic Oncology: Seminars and Original Investigations 24:3, pages 220-221.
Crossref
RODOLFO MONTIRONI, ROBERTA MAZZUCCHELLI, MARINA SCARPELLI, ANTONIO LOPEZ‐BELTRAN, GREGOR MIKUZ, FERRAN ALGABA & LILIANE BOCCON‐GIBOD. (2006) Prostate carcinoma II: prognostic factors in prostate needle biopsies. BJU International 97:3, pages 492-497.
Crossref
RODOLFO MONTIRONI, ROBERTA MAZZUCCHELLI, MARINA SCARPELLI, ANTONIO LOPEZ‐BELTRAN & GREGOR MIKUZ. (2006) Prostate carcinoma I: prognostic factors in radical prostatectomy specimens and pelvic lymph nodes. BJU International 97:3, pages 485-491.
Crossref
Antonio Lopez-Beltran, Gregor Mikuz, Rafael J. Luque, Roberta Mazzucchelli & Rodolfo Montironi. (2005) Current practice of Gleason grading of prostate carcinoma. Virchows Archiv 448:2, pages 111-118.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.